DOSAGE FORMS OF TISSUE KALLIKREIN 1
Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0 µg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for trea...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
13.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!